Related Experiment Video
Updated: Aug 8, 2026
10:13
Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding
Published on: June 9, 2017
[(35)S]GTPgammaS binding stimulated by endomorphin-2 and morphiceptin analogs
Jakub Fichna1, Jean-Claude do-Rego, Piotr Kosson
1Laboratory of Biomolecular Chemistry, Institute of Biomedicinal Chemistry, Medical University, Lodz, Poland.
Summary
Structural modifications to mu-opioid peptides like endomorphins and morphiceptins can alter their function. Some analogs act as agonists, while others become antagonists, affecting G-protein activation.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Mu-opioid peptides are crucial in pain modulation.
- Understanding their G-protein activation is key to developing targeted therapeutics.
- Structural variations can significantly impact opioid peptide activity.
Purpose of the Study:
- To investigate how structural modifications in mu-opioid peptides affect G-protein activation.
- To compare the G-protein activating potency of endomorphins, morphiceptin, and their analogs.
- To determine the agonist or antagonist properties of modified opioid peptides.
Main Methods:
- Utilized rat thalamus membrane preparations.
- Measured G-protein activation using a [(35)S]GTPgammaS binding assay.
- Compared modified peptides ([d-1-Nal(3)]Morphiceptin, [d-2-Nal(3)]Morphiceptin, endomorphin-2 analogs) with DAMGO.
Main Results:
- [d-1-Nal(3)]Morphiceptin demonstrated higher G-protein activation potency (EC50=82.5±4.5 nM) than DAMGO (EC50=105±9 nM).
- [d-2-Nal(3)]Morphiceptin and certain endomorphin-2 analogs acted as potent antagonists against DAMGO.
- Peptide modifications at positions 3 and 4 influenced the mode of action (agonist vs. antagonist).
Conclusions:
- The topographical placement of aromatic rings in modified opioid peptides dictates their functional outcome.
- Specific structural changes can convert potent agonists into effective antagonists.
- This highlights the potential for fine-tuning opioid peptide activity through targeted structural modifications.
Related Concept Videos
01:09GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...
01:22Activation and Inactivation of G Proteins
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...
01:11IP3/DAG Signaling Pathway
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
01:12GPCR Desensitization
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
01:30Transducer Mechanism: G Protein–Coupled Receptors
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical, 7TM, or...
GPCRs are also called heptahelical, 7TM, or...
01:16Calmodulin-dependent Signaling
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...